Lucia Novak, director of Riverside Diabetes Center in Maryland, defines clinical inertia and outlines patient- and practitioner-level factors that may impede appropriate management of your patients’...
Kevin Stewart, director of Environmental Health, Advocacy, and Public Policy at the American Lung Association of the Mid-Atlantic, explains the dangers of radon as the second-leading cause of lung cancer in...
Dr Mikhail Kosiborod from Saint Luke's Cardiovascular Consultants discusses the cardiologist's role in treating diabetes, when a diabetes specialist should be consulted, and the overall takeaway for...
In the second installment of this 2-part podcast, Dr Jane K Dickinson of Teachers College, Columbia University discusses the key takeaways of her talk at the 2018 Cardiometabolic Risk Summit, “Language...
In the first installment of this 2-part podcast, Dr Jane K Dickinson of Teachers College, Columbia University, discusses the importance of using appropriate language when treating people who have diabetes,...
Consultant360 spoke with Blánaid Hicks, PhD, BSc, from Queen’s University Belfast, whose study found that the use of angiotensin converting enzyme inhibitors may be tied to an increased lung cancer risk...
New research presented at the American Society of Nephrology’s Kidney Week 2018 suggests that 2 key indicators of renal function may help assess the likelihood of experien
A new study has shown that adding sulfonylureas to first-line metformin treatment is likely a safer option than switching to sulfonylureas entirely in patients with type 2 diabetes. Consultant360 spoke with...
In this podcast, Dr Laura Hollar from Washington University School of Medicine discusses her latest Diabetes Q&A column about the interaction between diabetes and vitamin D deficiency.
